A detailed history of Mackenzie Financial Corp transactions in Medtronic PLC stock. As of the latest transaction made, Mackenzie Financial Corp holds 692,962 shares of MDT stock, worth $56.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
692,962
Previous 654,839 5.82%
Holding current value
$56.2 Million
Previous $51.5 Million 21.04%
% of portfolio
0.09%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.84 - $91.03 $2.93 Million - $3.47 Million
38,123 Added 5.82%
692,962 $62.4 Million
Q2 2024

Aug 14, 2024

BUY
$78.71 - $87.02 $11.7 Million - $12.9 Million
148,586 Added 29.35%
654,839 $51.5 Million
Q1 2024

May 10, 2024

BUY
$82.84 - $88.09 $2.38 Million - $2.53 Million
28,741 Added 6.02%
506,253 $44.1 Million
Q4 2023

Jan 30, 2024

BUY
$69.43 - $83.43 $3.42 Million - $4.11 Million
49,270 Added 11.51%
477,512 $39.3 Million
Q3 2023

Oct 25, 2023

BUY
$78.22 - $90.4 $3.03 Million - $3.51 Million
38,788 Added 9.96%
428,242 $33.6 Million
Q2 2023

Aug 03, 2023

SELL
$79.47 - $91.38 $26,304 - $30,246
-331 Reduced 0.08%
389,454 $34.3 Million
Q1 2023

Apr 24, 2023

BUY
$76.72 - $87.58 $29.9 Million - $34.1 Million
389,785 New
389,785 $31.4 Million
Q3 2022

Oct 07, 2022

SELL
$80.75 - $95.31 $18.7 Million - $22 Million
-231,116 Reduced 13.5%
1,480,286 $120 Million
Q2 2022

Aug 10, 2022

SELL
$87.4 - $113.09 $4.08 Million - $5.27 Million
-46,634 Reduced 2.65%
1,711,402 $154 Million
Q1 2022

May 13, 2022

SELL
$100.58 - $112.38 $19.1 Million - $21.4 Million
-190,166 Reduced 9.76%
1,758,036 $195 Million
Q4 2021

Feb 14, 2022

SELL
$99.53 - $127.75 $47.4 Million - $60.8 Million
-475,930 Reduced 19.63%
1,948,202 $202 Million
Q3 2021

Nov 08, 2021

SELL
$122.75 - $135.17 $12.9 Million - $14.2 Million
-105,041 Reduced 4.15%
2,424,132 $304 Million
Q2 2021

Aug 11, 2021

BUY
$118.19 - $131.5 $24.2 Million - $26.9 Million
204,641 Added 8.8%
2,529,173 $314 Million
Q1 2021

May 14, 2021

BUY
$111.18 - $119.74 $69.2 Million - $74.5 Million
622,550 Added 36.58%
2,324,532 $275 Million
Q4 2020

Feb 10, 2021

BUY
$100.57 - $117.14 $90 Million - $105 Million
895,260 Added 110.98%
1,701,982 $199 Million
Q3 2020

Nov 13, 2020

BUY
$90.13 - $108.78 $22.1 Million - $26.6 Million
244,867 Added 43.58%
806,722 $83.8 Million
Q2 2020

Aug 13, 2020

SELL
$84.11 - $103.33 $2.41 Million - $2.96 Million
-28,664 Reduced 4.85%
561,855 $51.5 Million
Q1 2020

May 14, 2020

BUY
$72.92 - $121.3 $37.1 Million - $61.7 Million
508,340 Added 618.58%
590,519 $53.3 Million
Q4 2019

Feb 13, 2020

SELL
$104.49 - $114.54 $9.74 Million - $10.7 Million
-93,258 Reduced 53.16%
82,179 $9.32 Million
Q3 2019

Nov 14, 2019

SELL
$98.02 - $111.18 $2.91 Million - $3.3 Million
-29,697 Reduced 14.48%
175,437 $19.1 Million
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $24.1 Million - $28.4 Million
-285,837 Reduced 58.22%
205,134 $20 Million
Q1 2019

May 15, 2019

SELL
$82.45 - $93.79 $75 Million - $85.3 Million
-909,352 Reduced 64.94%
490,971 $44.7 Million
Q4 2018

Feb 06, 2019

BUY
$85.8 - $99.49 $283,998 - $329,311
3,310 Added 0.24%
1,400,323 $127 Million
Q3 2018

Nov 15, 2018

BUY
$85.91 - $99.17 $26.6 Million - $30.6 Million
309,049 Added 28.41%
1,397,013 $137 Million
Q2 2018

Aug 13, 2018

BUY
$77.48 - $87.83 $8.63 Million - $9.79 Million
111,410 Added 11.41%
1,087,964 $93.1 Million
Q1 2018

May 14, 2018

BUY
$76.55 - $87.26 $2.78 Million - $3.17 Million
36,329 Added 3.86%
976,554 $78.3 Million
Q4 2017

Feb 13, 2018

BUY
$76.93 - $83.5 $71.6 Million - $77.7 Million
930,956 Added 10043.76%
940,225 $75.9 Million
Q3 2017

Nov 13, 2017

BUY
$77.71 - $84.6 $20,593 - $22,419
265 Added 2.94%
9,269 $721,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,004
9,004 $799,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.